Cost-effectiveness of treatment in adults with blood pressure of 130–139/80–89 mmHg and high cardiovascular risk in China: a modelling study
- Resource Type
- Article
- Source
- In
The Lancet Regional Health - Western Pacific January 2024 42 - Subject
- Language
- ISSN
- 2666-6065